ArticleEULAR rheumatology open2026
The epidemiology of inflammatory rheumatic diseases in Germany in a European context: a systematic review to support workforce planning.
Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The number of adults living with inflammatory rheumatic diseases (iRMDs) in a country is key for calculating the demand for rheumatologists. Our aim was to estimate the incidence and prevalence of iRMD in Germany by compiling current epidemiologic German and other European data. Methods: A systematic review included original studies on prevalence and incidence of iRMDs in Germany and other European countries, covering study data from 2013 to the present. Considering heterogeneous methodology, we qualitatively estimated the prevalence and incidence for 11 iRMDs and extrapolated the results to the German population. Results: A total of 20 German and 72 studies from other European countries were considered. All German studies used claims data with moderate to high risk of bias. Studies relying solely on Conclusions: This study compiles European epidemiological data on 11 iRMDs to calculate the number of people affected. The methodology could be a blueprint for studies in other regions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.